p35/Cdk5 pathway mediates soluble amyloid-β peptide-induced tau phosphorylation in vitro

Journal of Neuroscience Research

Volumn 69, Issue 3, 2002, Pages 362-372

  Town, Terrence ^a   Zolton, Joseph ^a   Shaffner, Reed ^a   Schnell, Billy ^a   Crescentini, Robert ^a   Wu, Yajuan ^a   Zeng, Jin ^a   DelleDonne, Anthony ^a   Obregon, Demian ^a   Tan, Jun ^a   Mullan, Mike ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Calcium; Calpain; N2a cells; Tau

Indexed keywords

AMYLOID BETA PROTEIN; ANTISENSE OLIGONUCLEOTIDE; CALCIUM CHANNEL L TYPE; CALPAIN; CYCLIN DEPENDENT KINASE 5; PROTEIN P25; PROTEIN P35; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOG; DYSTROPHY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME SPECIFICITY; EPITOPE MAPPING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PEPTIDE ANALYSIS; PRIMATE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SENILE PLAQUE; SHORT SURVEY;

AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, WESTERN; CALCIUM CHANNELS, L-TYPE; CALPAIN; CELL CULTURE TECHNIQUES; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE TISSUE PROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TAU PROTEINS; TRANSFECTION; UP-REGULATION;

EID: 0036682362     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10299     Document Type: Short Survey

References (40)

1. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons
2. Alpha-adrenergic antagonists as possible calcium channel inhibitors
3. Evolution of neuronal changes in the course of Alzheimer's disease
4. Age, neurofibrillary changes. A beta-amyloid and the onset of Alzheimer's disease
5. Tau protein function in living cells
6. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants
7. Tricresyl phosphate inhibits the formation of axon-like processes and disrupts neurofilaments in cultured mouse N2a and rat PC12 cells
8. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology
9. Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment
10. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: Identification of phosphorylation sites in tau protein
11. Structure of tau protein and assembly into paired helical filaments
12. Epitopes that span the tau molecule are shared with paired helical filaments
13. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
14. Neurotoxicity induces cleavage of p35 to p25 by calpain
15. Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau
16. Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry
17. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex
18. Effects of microtubule stabilization and destabilization on tau immunoreactivity in cultured hippocampal neurons
19. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
20. Re-entry into the cell cycle: A mechanism for neurodegeneration in Alzheimer disease
21. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes
22. Isolation of microtubule protein from cultured mouse neuroblastoma cells
23. Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth
24. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
25. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation
26. Cyclin' toward dementia: Cell cycle abnormalities and abortive oncogenesis in Alzheimer disease
27. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments
28. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons
29. Involvement of cyclin dependent kinase 5 activator p25 on tau phosphorylation in mouse brain
30. Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta1 and IL-10
31. The ultrastructure of the neurofibrillary tangle and the senile plaque
32. Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice
33. Receptor protein tyrosine phosphatase alpha participates in the ml muscarinic acetylcholine receptor-dependent regulation of Kv1.2 channel activity
34. Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice
35. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease
36. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging
37. Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study
38. Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys
39. Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells
40. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease